Treatment of high-grade serous ovarian cancer (HGSOC) will benefit from early detection of cancer. Here, we provide proof-of-concept data supporting the hypothesis that circulating immune cells, because of their early recognition of tumors and the tumor microenvironment, can be considered for biomarker discovery.

中文翻译：

---

通过挖掘循环免疫细胞的转录组来识别新的卵巢肿瘤生物标志物：概念验证研究

高级别浆液性卵巢癌 (HGSOC) 的治疗将受益于癌症的早期发现。在这里，我们提供了概念验证数据来支持这样的假设，即循环免疫细胞，因为它们对肿瘤和肿瘤微环境的早期识别，可以考虑用于生物标志物的发现。